Savigny sur Orge, France

Neerja Bhatnagar


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Savignv-sur-Orge, FR (1994)
  • Savigny-Sur-Orge, FR (1994 - 2007)
  • Neshanic Station, NJ (US) (2006 - 2009)

Company Filing History:


Years Active: 1994-2009

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Neerja Bhatnagar: Innovator in Medicinal Chemistry

Introduction

Neerja Bhatnagar is a prominent inventor based in Savigny sur Orge, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of 14 patents to her name, her work has had a substantial impact on the pharmaceutical industry.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof." This invention relates to the preparation of substituted caprolactams, which are used as medicaments, particularly as anticancer agents. The second patent is for "2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof." This invention focuses on the preparation and use of these compounds as medicaments, also targeting cancer treatment.

Career Highlights

Neerja Bhatnagar has worked with several reputable companies in the pharmaceutical sector. Notably, she has been associated with Aventis Pharma and Roussel Uclaf. Her experience in these organizations has contributed to her expertise in developing innovative medicinal compounds.

Collaborations

Throughout her career, Neerja has collaborated with various professionals in her field. Some of her notable coworkers include Jean Buendia and Christine Griffoul, who have contributed to her research and development efforts.

Conclusion

Neerja Bhatnagar's contributions to medicinal chemistry and her innovative patents highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in cancer treatment and other medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…